Endostatin competes with bFGF for binding to heparin-like glycosaminoglycans
- 1 August 2005
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 333 (3) , 976-983
- https://doi.org/10.1016/j.bbrc.2005.06.011
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Angiogenesis in health and diseaseNature Medicine, 2003
- Phase I Study of Recombinant Human Endostatin in Patients With Advanced Solid TumorsJournal of Clinical Oncology, 2002
- Phase I Clinical Trial of Recombinant Human Endostatin Administered as a Short Intravenous Infusion Repeated DailyJournal of Clinical Oncology, 2002
- Antiangiogenic therapy of experimental cancer does not induce acquired drug resistanceNature, 1997
- Mechanisms of angiogenesisNature, 1997
- Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor GrowthCell, 1997
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisPublished by Elsevier ,1996
- Angiogenesis in cancer, vascular, rheumatoid and other diseaseNature Medicine, 1995
- Alpha 1(XVIII), a collagen chain with frequent interruptions in the collagenous sequence, a distinct tissue distribution, and homology with type XV collagen.Proceedings of the National Academy of Sciences, 1994
- Isolation and sequencing of cDNAs for proteins with multiple domains of Gly-Xaa-Yaa repeats identify a distinct family of collagenous proteins.Proceedings of the National Academy of Sciences, 1994